Table 2. Values of odds ratio (OR) and 95% confidence interval (95% CI) for diabetes mellitus type 2 (DM2) and systemic arterial hypertension (SAH) before and after bariatric surgery, according to each gene polymorphism.
Gene Polymorphism | Genotype | n (%) | DM2 Preoperative | SAH Preoperative | ||
---|---|---|---|---|---|---|
| ||||||
OR (95% CI) | p-value | OR (95% CI) | p-value | |||
GHRL rs26802 | CC | 35 (10) | 1.00 | 0.921 | 1.00 | 0.563 |
CA + AA | 316 (90) | 1.045 (0.436–2.507) | 1.244 (0.593–2.609) | |||
GHSR rs572169 | GG | 211 (60) | 1.00 | 0.547 | 1.00 | 0.443 |
GA + AA | 140 (40) | 0.722 (0.250–2.085) | 1.441 (0.566–3.667) | |||
LEP rs7799039 | AA | 53 (15) | 1.00 | 0.318 | 1.00 | 0.274 |
AG + GG | 298 (85) | 0.652 (0.282–1.508) | 0.712 (0.388–1.307) | |||
LEPR rs1137101 | GG | 73 (21) | 1.00 | 0.974 | 1.00 | 0.945 |
AG + AA | 278 (79) | 0.989 (0.514–1.902) | 1.019 (0.596–1.742) | |||
5–HT2C rs3813929 | TT/CT | 87 (25) | 1.00 | 0.001 | 1.00 | 0.556 |
CC | 264 (75) | 0.251 (0.109–0.578) | 1.164 (0.702–1.928) | |||
UCP2 rs659366 | TT | 49 (14) | 1.00 | 0.505 | 1.00 | 0.884 |
CT + CC | 302 (86) | 1.330 (0.574–3.082) | 1.056 (0.511–2.181) | |||
UCP2 rs660339 | AA | 49 (14) | 1.00 | 0.238 | 1.00 | 0.675 |
AG + GG | 302 (86) | 0.568 (0.222–1.452) | 1.167 (0.567–2.405) | |||
UCP3 rs1800849 | CC | 54 (15) | 1.00 | 0.019 | 1.00 | 0.128 |
CT + TT | 297 (85) | 0.305 (0.113–0.821) | 0.624 (0.341–1.144) | |||
SH2B1 rs7498665 | GG | 223 (64) | 1.00 | 0.594 | 1.00 | 0.946 |
AG + AA | 294 (84) | 0.815 (0.385–1.726) | 0.980 (0.544–1.765) | |||
TAS1R2 rs35874116 | CC + CT | 184 (52) | 1.00 | 0.790 | 1.00 | 0.933 |
TT | 167 (48) | 1.706 (0.626–1.850) | 1.019 (0.658–1.579) | |||
TAS1R2 rs9701796 | GG + CG | 117 (33) | 1.00 | 0.353 | 1.00 | 0.341 |
CC | 234 (67) | 0.761 (0.428–1.354) | 1.252 (0.788–1.989) | |||
FTO rs9939609 | AA | 71 (20) | 1.00 | 0.911 | 1.00 | 0.058 |
AT + TT | 280 (80) | 0.963 (0.492–1.882) | 0.595 (0.348–1.017) |
n = 351. Variables with adjustments for age, skin color, preoperative BMI, previous pregnancy and age at onset of obesity.